In addition, blocking the estrogen receptor in vivo in female mice increases parasitemia, aggravates pathology, augments CD8+ and B220+ populations and decreases IL-2, IL-6, and IL-17 concentrations (Cervantes-Candelas et al., 2021a). This evidence concerns the gene PTPRC and parasitic infectious disease.